JLab announces college sports sponsorships
JLab Kicks Off College Sports Program to Champion Student Athlete Success
February 22, 2024 09:01 ET | JLab Audio
San Diego, CA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- JLab today announced a comprehensive college sports program that will support 17 D1 schools along with student athletes across men’s and women’s...
Figure 1
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease
September 25, 2023 11:22 ET | Trethera Corporation
LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
Figure 1: Representative stained spinal cord sections from a mouse ADEM model. Arrows point to regions of leukocyte infiltration
Trethera Receives NIH Grant for Preclinical Development in the Pediatric Neurologic Disease Acute Disseminated Encephalomyelitis
August 14, 2023 11:23 ET | Trethera Corporation
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
PET scan images showing presence of target enzyme dCK in normal mice (row A), and lupus diseased mice (row B).
Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
June 27, 2023 11:14 ET | Trethera Corporation
LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment...
Company LOGO 1 (1).jpg
NewHydrogen Promotes Steven Hill to Chief Executive Officer
June 16, 2023 03:30 ET | NewHydrogen, Inc.
SANTA CLARITA, Calif., June 16, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTC:NEWH), the developer of a breakthrough technology to produce low-cost green hydrogen, today announced that Steven Hill...
PharmAla Biotech Logo 800 x 422.png
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
June 09, 2023 15:48 ET | PharmAla Biotech
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...
Figure 1
Trethera Receives $2 Million National Cancer Institute Grant for Advancement of Clinically Relevant Biomarkers in Phase 1 Trial
May 30, 2023 12:16 ET | Trethera Corporation
LOS ANGELES, May 30, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...
HOK Logo.JPG
HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District
April 27, 2023 11:00 ET | HOK
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...
Company LOGO 1 (1).jpg
NewHydrogen Names Steven Hill as Vice President
March 20, 2023 03:30 ET | NewHydrogen, Inc.
Having served in a prominent sales and marketing role in the biopharmaceutical industry, Hill brings extensive business development experience needed to help the company scale. SANTA CLARITA,...
Co-crystal 3D structure of the drug bound to the target enzyme, dCK, at the deoxycytidine binding site.
Dose Escalation Portion of Phase 1 Solid Tumors Trial Produces Favorable Results in Heavily Pretreated Solid Tumor Patients
March 15, 2023 11:55 ET | Trethera Corporation
LOS ANGELES, March 15, 2023 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for...